Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Vet Radiol Ultrasound ; 65(3): 308-316, 2024 May.
Article in English | MEDLINE | ID: mdl-38549218

ABSTRACT

A chronic cough, gag, or retch is a common presenting clinical complaint in dogs. Those refractory to conservative management frequently undergo further diagnostic tests to investigate the cause, including CT examination of their head, neck, and thorax for detailed morphological assessment of their respiratory and upper gastrointestinal tract. This case series describes five patients with CT characteristics consistent with an intracranial and jugular foraminal mass of the combined glossopharyngeal (IX), vagus (X), and accessory (XI) cranial nerves and secondary features consistent with their paresis. The consistent primary CT characteristics included an intracranial, extra-axial, cerebellomedullary angle, and jugular foraminal soft tissue attenuating, strongly enhancing mass (5/5). Secondary characteristics included smooth widening of the bony jugular foramen (5/5), mild hyperostosis of the petrous temporal bone (3/5), isolated severe atrophy of the ipsilateral sternocephalic, cleidocephalic, and trapezius muscles (5/5), atrophy of the ipsilateral thyroarytenoideus and cricoarytenoideus muscles of the vocal fold (5/5), and an ipsilateral "dropped" shoulder (4/5). Positional variation of the patient in CT under general anesthesia made the "dropped" shoulder of equivocal significance. The reported clinical signs and secondary CT features reflect a unilateral paresis of the combined cranial nerves (IX, X, and XI) and are consistent with jugular foramen syndrome/Vernet's syndrome reported in humans. The authors believe this condition is likely chronically underdiagnosed without CT examination, and this case series should enable earlier CT diagnosis in future cases.


Subject(s)
Dog Diseases , Glossopharyngeal Nerve , Jugular Foramina , Tomography, X-Ray Computed , Vagus Nerve , Animals , Dogs , Female , Accessory Nerve/diagnostic imaging , Cranial Nerve Neoplasms/veterinary , Cranial Nerve Neoplasms/diagnostic imaging , Dog Diseases/diagnostic imaging , Glossopharyngeal Nerve/diagnostic imaging , Jugular Foramina/diagnostic imaging , Tomography, X-Ray Computed/veterinary , Vagus Nerve/diagnostic imaging , Vagus Nerve Diseases/veterinary , Vagus Nerve Diseases/diagnostic imaging , Vagus Nerve Diseases/diagnosis , Vagus Nerve Diseases/pathology , Retrospective Studies
2.
J Vet Intern Med ; 33(3): 1141-1172, 2019 May.
Article in English | MEDLINE | ID: mdl-30847984

ABSTRACT

Immune-mediated hemolytic anemia (IMHA) causes severe anemia in dogs and is associated with considerable morbidity and mortality. Treatment with various immunosuppressive and antithrombotic drugs has been described anecdotally and in previous studies, but little consensus exists among veterinarians as to the optimal regimen to employ and maintain after diagnosis of the disease. To address this inconsistency and provide evidence-based guidelines for treatment of IMHA in dogs, we identified and extracted data from studies published in the veterinary literature. We developed a novel tool for evaluation of evidence quality, using it to assess study design, diagnostic criteria, explanation of treatment regimens, and validity of statistical methods. In combination with our clinical experience and comparable guidelines for humans afflicted with autoimmune hemolytic anemia, we used the conclusions of this process to make a set of clinical recommendations regarding treatment of IMHA in dogs, which we refined subsequently by conducting several iterations of Delphi review. Additionally, we considered emerging treatments for IMHA in dogs and highlighted areas deserving of future research. Comments were solicited from several professional bodies to maximize clinical applicability before the recommendations were submitted for publication. The resulting document is intended to provide clinical guidelines for management of IMHA in dogs. These guidelines should be implemented pragmatically, with consideration of animal, owner, and veterinary factors that may vary among cases.


Subject(s)
Anemia, Hemolytic, Autoimmune/veterinary , Dog Diseases/therapy , Anemia, Hemolytic, Autoimmune/therapy , Animals , Anticoagulants/administration & dosage , Anticoagulants/therapeutic use , Blood Transfusion/veterinary , Dog Diseases/immunology , Dogs , Female , Immunosuppressive Agents/administration & dosage , Immunosuppressive Agents/therapeutic use , Male , Platelet Aggregation Inhibitors/administration & dosage , Platelet Aggregation Inhibitors/therapeutic use
4.
J Feline Med Surg ; 13(8): 564-9, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21764618

ABSTRACT

A retrospective study was performed to investigate the frequency of identification and characteristics of oesophageal disease in cats, including assessment of the utility of diagnostic techniques and clinical outcome. Thirty-three cats met the inclusion criteria, giving an in-clinic frequency of 33/2894 (approximately 1%) of feline referral cases. Vomiting and/or regurgitation were the most common presenting signs described, although a number of cats (6/33) showed neither. Useful diagnostic modalities included plain radiography, fluoroscopy, barium radiography and endoscopy. A wide range of diseases was reported including congenital disease, oesophagitis, foreign body obstruction, neoplasia, extraluminal compression and hypomotility disorder. Five of six cats with acquired oesophageal strictures had recently received doxycycline per os.


Subject(s)
Cat Diseases/diagnosis , Cat Diseases/epidemiology , Esophageal Diseases/veterinary , Animals , Cat Diseases/therapy , Cats , Esophageal Diseases/diagnosis , Esophageal Diseases/epidemiology , Esophageal Diseases/therapy , Female , Male , Retrospective Studies , Treatment Outcome , United Kingdom/epidemiology , Vomiting/veterinary
5.
Curr Opin Immunol ; 16(6): 695-701, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15511660

ABSTRACT

The immune system is a delicately balanced network of interacting cells. In recent years, the concept of immune regulation/suppression has been firmly established, and both natural and induced regulatory cells play vital roles in protection from autoimmune disease. Recent work has revealed the diverse nature of regulatory CD4+ T (Treg) cells and the molecules involved in their function. Innate and adaptive responses to infection are able to override the suppressive properties of such regulatory cells, whereas several reports point to deficiencies in regulatory cell function in autoimmune disease. Protocols have been developed that allow the expansion of Treg cells in vitro and their antigen-specific induction in vivo. A full understanding of Treg differentiation and function will facilitate the development of improved strategies for prevention and treatment of autoimmune diseases.


Subject(s)
Autoimmune Diseases/immunology , CD4-Positive T-Lymphocytes/immunology , T-Lymphocyte Subsets/immunology , Animals , Autoimmune Diseases/therapy , Humans , Immunotherapy, Adoptive , Lymphocyte Activation/immunology , Mice
SELECTION OF CITATIONS
SEARCH DETAIL
...